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October 26, 2018 cells, and smooth muscle cells. 10 Previous studies demonstrated that CDC transplantation produces functional and structural benefits for injured heart through potential stimulation of endogenously regenerative responses. 11 Interestingly, a recent study indicated that transplantation of CDCs into aging rat hearts could rejuvenate cardiac function, exercise capacity, and hair regrowth capacity. 12 In this study, we aimed to address whether CDCs could improve cardiac function in aging mice.
Methods
The authors declare that all methods and supporting data are available within the article and its Online Data Supplement.
Animal Studies
All experimental protocols involving animals in this study were approved by the Laboratory Animal Research Committee of Soochow University. To avoid the impact of sex differences, we used male C57BL/6 mice (21±0.8 months old) for CDC injection. After CDC injection for 30 days, aging-related parameters were detected. No abnormal death was observed during animal experiments. Young mice (2 months old, male) were used as control to characterize heart functional changes related to aging. Neonatal mice (3 days old, male:female=1:1) were used for CDCs isolation. These mice were purchased from Anhui Medical University Laboratory Animal Center.
Isolation and Maintenance of CDCs
Hearts were excised from neonatal mice to produce CDCs, as described. 13, 14 Briefly, heart tissues from postnatal day-3 C57BL/6 mice were cut into 1-to 2-mm fragments with sterile scissors. The small pieces of tissues were digested with 0.2% trypsin and 0.1% collagenase IV for 5 minutes at 37°C in a water bath. After gravity separation, the supernatant was discarded, and the remaining tissues were further digested twice at the same condition. The obtained tissues were cultured on fibronectin-coated dishes in explant medium containing 80% Iscove's Modified Dulbecco's Medium (IMDM), 20% fetal bovine serum (FBS), l-glutamine, 2-mercaptoethanol, and penicillin-streptomycin. After 1 to 2 weeks of culturing, fibroblast-like cells reached confluence with the phase-bright cells loosely attached to them. These phase-bright cells were collected by 2 washes with the explant medium, at a frequency of 4× at 5-day intervals. After centrifugation, the collected cells were suspended in a cardiospheregrowing medium containing 35% complete IMDM, 65% Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12), 2% B27, 1 unit/mL thrombin, 80 ng/mL bFGF (basic fibroblast growth factor), 25 ng/mL epidermal growth factor (EGF), 4 ng/mL cardiotrophin-1, 0.1 mmol/L 2-mercaptoethanol, 1% l-glutamine and antibiotics, and cultured on poly-d-lysine-coated 35 mm dishes at 0.5-1×10 5 cells/mL. After 7 days of culturing, the cardiospheres were transferred to fibronectin-coated dishes for attachment. Subsequently, CDCs were passaged at 1:2 ratio by trypsin digestion.
Flow Cytometry Assay
All flow cytometry assays were performed using a Millipore Guava easyCyte 8 (EMD Millipore), and data were analyzed by Guava InCyte software. Anti-mouse CD117-APC (17-1172-82, eBioscience), anti-mouse SCA-1-FITC (11-5981-82, eBioscience), antimouse CD34-FITC (11-0341-82, eBioscience), and anti-mouse CD31-FITC (558738, BD Biosciences) were used for cell-specific direct staining. The isotype-matched antibodies (17-4031-82 & 11-4321-80, eBioscience) were used for background fluorescence.
Animal Surgery
All C57BL/6 mice were maintained under specific pathogen-free conditions in compliance with the guidelines of the Animal Care and Use Committee and of Soochow University. After echocardiography, 21-month-old C57BL/B6 mice were divided randomly into 2 groups and received thoracotomy by a highly skilled microsurgeon (J.L.). The first group with 15 mice received Phosphate-buffered saline (PBS) injection. The second group with 19 mice was treated with CDCs. CDCs from the same strain were injected via a left thoracotomy after anesthesia. Cells were injected into the normal aging myocardium of left ventricle (LV) at 4 injection sites: anterior, lateral, posterior walls, and apex. Every site received 2.5×10 4 passage 5 cells in 2.5 μL PBS.
Echocardiographic Analysis
The Visual Sonics Vevo2100 system equipped with a medium frequency (30 MHz MS-400 transducer was used by an investigator (X.H.) blinded to group designation. Two-dimensional long-axis and short-axis LV imaging were collected for analysis. M-mode tracings were recorded through septum and posterior LV walls to measure LV dimension and wall thickness. LV end-diastolic diameter and endsystolic diameter were measured and used to calculate LV ejection fraction (LVEF) and LV fraction shortening. Pulse-wave Doppler and tissue Doppler imaging were recorded from the apical 4-chamber view. E (the peak early transmitral flow velocity), A (the peak late transmitral flow velocity), E/A (the ratio of the peak early transmitral flow velocity to the peak late transmitral flow velocity), and E/Eʹ (the ratio of peak early transmitral flow velocity to the peak early diastolic mitral annular velocity) were measured and analyzed. 
Pressure-Volume Loop Measurement
Invasive steady-state hemodynamic measurements were performed (n=7 for PBS injection group, n=7 for CDC injection group) according to a previous publication. 15 Briefly, after anesthesia, mice were intubated and maintained under controlled respiration. A 1.4F conductance catheter (Millar Instruments, Houston, TX) was introduced into the LV through the apex for data collection. Data for determination of LV end-diastolic relationship and end-systolic pressure-volume relationship were obtained by temporary inferior vena cava occlusion. The signals were continuously recorded using a pressure-volume conductance system (MPVS ULTRA, Millar Instruments) coupled to PowerLab 8/35 (AD Instruments, Colorado Springs, Colo). Data were collected and analyzed by LabChart 8 software (AD Instruments).
Treadmill Exercise Capacity
At 28 days post-surgery, the mice (n=10 per group) were acclimated to the treadmill at a speed of 5 m/min for 15 minutes before each test. The initial speed was set at 10 m/min. During the test, the treadmill velocity was increased 1 m/min every 30 seconds. Mice were defined exhaustion when they stayed on the shock grid for 15 consecutive seconds. The maximal running speed was recorded.
Hair Regrowth Assay After Surgery
Chest ventral hairs were removed using depilatory cream before thoracotomy. After 20 days, hair regrowth areas were photographed and analyzed using Image J software. Hair regrowth was analyzed by measuring the area of regrowth areas (areas of high hair density) and expressed as a percentage of the total shaved area. For hair regrowth length measurement, regrown hairs were plucked out. The average length of 20 hairs per mouse was recorded as hair regrowth length. Five mice from each group were included.
Histological Examination and Telomere Length Measurement
Hearts from PBS and CDC groups were harvested, fixed, dehydrated, and immersed in optimum cutting temperature compound. Serial 5-μm thick sections were collected via cryotome. To determine the fibrotic degree of heart, sections were stained with Masson trichrome using Trichrome Stain (Masson) kit (Sigma) as per the manufacture's protocol. Collagen deposition was visualized as blue staining.
To quantify the size of cardiomyocytes, the slides were stained using wheat germ agglutinin (Alexa 594 conjugated, W11262, Thermo Fisher). Briefly, after being fixed in 4% paraformaldehyde, the slides were washed with PBS 3× and then incubated with 5 µg/mL wheat germ agglutinin for 1 hour at room temperature. After 2 washes in PBS, the sections were permeabilized with 0.2% Triton X in PBS for 15 minutes. Then the slides were incubated with antisarcomeric α-actinin (1:100, ab9465, Abcam) to stain cardiomyocytes. Hoechst 33342 was used for nuclear counterstaining. Images were captured under a laser scanning confocal microscopy (Zeiss, LSM 880). The cross-sectional areas of cardiomyocytes were quantified using Image J software as previously reported. 12 For telomere staining, we used the protocol of PNA (peptide nucleic acid) telomere probe for FISH (fluorescence in situ hybridization) from Panagene company. Briefly, the slides were rehydrated in PBS solution and fixed in 4% paraformaldehyde for 4 minutes at 37°C. Subsequently, the slides were washed and treated with RNase A solution (100 µg/mL, 2158, Takara) for 1 hour at 37°C and immersed in 0.005% pepsin (10108057001, Roche) for 4 minutes at 37°C. After another round of fixation and washes, the sections were then dehydrated with ethanol series (for 1 minute in 70%, 85%, and 100%) and air dried. Next, the slides were incubated with 200 nmol/L telomeric Cy3-TelG 5ʹ-(TTAGGG)3-3ʹ PNA probe (F1006, Panagene) at 85°C for 10-minute denaturation and placed in the dark at room temperature for 1 hour. 16, 17 After 2 washes at 58°C, the primary antibody for sarcomeric α-actinin (1:100, ab9465, Abcam) and Alexa Fluor 488-conjugated donkey anti-mouse secondary antibody (200-542-156, Jackson ImmunoResearch) were used to distinguish cardiomyocytes from nonmyocytes. Hoechst 33342 was used for nuclear staining. Telomere signals were captured using a laser scanning confocal microscopy (Zeiss, LSM 880) under the same condition. The integrated optical density and the numbers of spots were obtained using Image J software as previously reported. 18 The average integrated optical density per spot within nucleus was defined as telomere length. A total of 267, 240, and 274 nuclei were measured from young mice, PBS-and CDC-treated aging mice (n=5 for each group), respectively. Normal distribution was calculated using Excel software.
Quantitative Real-Time Polymerase Chain Reaction (PCR) Analysis
Invitrogen TRIzol reagent (Thermo Fisher) was used to extract total RNA from 6 LVs from each group. After DNase I digestion, an aliquot of total RNA (500 ng) was reverse transcribed into single-strand cDNA using the Takara PrimeScript RT Reagent Kit (RR037A, Takara). RNA expression was detected and analyzed using the Applied Biosystems StepOnePlus Real-Time PCR System (Thermo Fisher). Values were normalized to 18S rRNA to calculate the relative expression level. All primer sequences were listed in Online Table I . MicroRNA reverse transcription was performed using Mir-X microRNA First-Strand Synthesis Kit (638313, Takara). The procedure for telomere length detection by real-time PCR followed a previous report.
19
Inflammation Factor Examination
The sera from mice with PBS (n=5) and CDC injection (n=5) were collected after cell transplantation for 1 month. Enzyme-linked immunosorbent assay (ELISA) kits were used to assess the content of inflammation factors, including IL (interleukin)-1β (88-7013, Invitrogen), IL-6 (ab100712, Abcam), and TNF (tumor necrosis factor)-α (ab208348, Abcam).
Western Blot
Western blot was performed as previously described. 20 CTGF (connective tissue growth factor; ab6992, Abcam) and p16 (10883-1-AP, Proteintech) antibodies were used for proteins detection.
Bioluminescence Imaging
To study the retention of transplanted cells, CDCs were transfected with a lentivirus for luciferase expression. After cell injection as described above, in vivo bioluminescence imaging was performed with IVIS Spectrum. After intraperitoneal injection of the substrate D-luciferin (200 mg/kg body weight) for 10 minutes, animals were recorded for 10 minutes with 1-minute acquisition intervals. Peak signals from a fixed region of interest were obtained and quantified in units of photons per second per centimeter squared per steradian as previously described. 
Statistical Analysis
Comparisons between 2 groups were analyzed using Student t test. Comparisons in multiple groups were analyzed with 1-way ANOVA. Statistical significance was denoted by a P<0.05. All data were presented as mean±SEM. All experimental assays were performed at least in triplicates. The person who analyzed results was blinded as to the treatment. For sample size and power calculation, echocardiographic analysis on young and old mice was performed to determine aging-related parameters, for which LV posterior wall thickness (LVPW) was a reliable aging-related end point. A previous report 12 found that LVPW decreased 12.5% (0.2/1.6) after CDCs injection. In our study, LVPW of normal aging heart is 0.957±0.043 (Online Table II ). Sample sizes (PBS, n=15; CDCs, n=19) were large enough at power >80%. The calculation was done by using online software (http://clincalc.com/stats/samplesize.aspx).
Results
Isolation and Characterization of CDCs
To obtain CDCs, we minced and digested heart tissues from postnatal 3-day mice. Typical heart explants were observed on fibronectin-coated dishes after 2 days of culturing, with e24
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October 26, 2018 some fibroblasts migrating from it ( Figure 1A ). After 12 days of culturing, fibroblast-like cells reached confluence with the phase-bright cells loosely attached to them ( Figure 1B) . The phase-bright cells were collected and cultured on poly-d-lysine-coated dishes in cardiosphere-growing medium, and dividing cells could be observed ( Figure 1C ). After 7 days of culturing, the cardiospheres with 100 to 200 μm sizes were formed with spontaneous beating ( Figure 1D ; Online Movie I), and these cardiospheres were transferred to fibronectin-coated dishes for attachment and subsequent passaging ( Figure 1E and 1F). These cells were identified through flow cytometry for the expressions of CD117 (c-Kit), SCA-1, CD34, and CD31 ( Figure 1G through 1J) , showing typical CDC phenotypes. The CDCs rejuvenation capacity on aging heart was then determined by the experimental procedure shown in Figure 1K .
Comparison of Heart Function After Cardiac Injection of CDCs Into Aging Mice
Before surgery, we randomly separated the aging mice into PBS and CDC transplantation groups. Echocardiography was used to evaluate LV function before and after injection, and the representative images of M-mode were shown in Figure 2A , and data were shown in Online Table III . Before cell injection, the LVEF, LV fraction shortening, LVPW at end diastole (LVPW; d), and LVPW at end systole were comparable in the 2 groups. We reevaluated heart function 1 month after injection of PBS and CDCs but did not obtained significant differences between PBS and CDC groups in term of LVEF and LV fraction shortening values ( Figure 2B and 2C). LVPW; d was significantly increased after CDC injection for 1 month, resulting in reduced diastolic LV volume ( Figure 2D ; Online Table III) , whereas the LVPW at end-systole showed no significant differences between PBS and CDC injection groups ( Figure 2E ). We also performed pulse-wave Doppler and tissue Doppler imaging in PBSand CDC-injected mice to evaluate the diastolic function of hearts ( Figure 2F ). After 1 month, aging mice that had been transplanted with CDCs showed comparable values of E, A, E/A, and E/Eʹ ( Figure 2G through 2J) . The invasive hemodynamic measurements were performed to evaluate heart function of aging mice ( Figure 3A ; Online Table III ). Unfortunately, after 1 month of CDC injection, we did not find significant differences in both the slope of LV end-systolic pressure-volume relationship and enddiastolic pressure-volume relationship ( Figure 3B and 3C) . Collectively, no significant differences were observed in general LV function between PBS-and CDC-injected aging mice.
Postmortem Analysis of Aging Mouse Hearts
Masson trichrome staining indicated that the injection sites of aging heart showed obvious fibrotic staining in both groups, probably because of needle injury on injection, indicating intramyocardial injection may not be appropriate for aging mice. However, there were no significant differences in peri-injection sites and noninjection site of aging heart between PBS and and tissue Doppler imaging (TDI) in aging mice injected with PBS vs CDCs. G, E (the peak early transmitral flow velocity) values were comparable in both PBS-and CDC-injected groups. H, A (the peak late transmitral flow velocity) values showed no significant differences between PBS-and CDC-injected groups. I, E/A (the ratio of the peak early transmitral flow velocity to the peak late transmitral flow velocity) ratios were comparable in both groups. J, E/E′ (the ratio of peak early transmitral flow velocity to the peak early diastolic mitral annular velocity) ratios showed no significant differences for both groups. *P<0.05; NS indicates not significant, as indicated, ANOVA. PBS (n=15), CDCs (n=19). Each experiment was performed 3×.
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CDC injection groups ( Figure 4A ). The similar expression levels of fibrotic marker Ctgf were found by real-time PCR and Western blot with ex vivo hearts from both groups, confirming the comparable fibrotic degree ( Figure 4B ; Online Figure I ). We also tested several cell cycle and aging-related genes ( Figure 4C ). Although Serca2, Lpl, and p16 mRNAs were significantly increased in aging mice, we did not find agingrelated gene changes between PBS and CDC injection groups. Western blot confirmed that the expression of p16 protein was comparable between PBS-and CDC-injected hearts (Online Figure I) . Furthermore, aging-related microRNAs were detected. The expressions of miR-21, miR-22, and miR-34a were significantly upregulated in aging mouse hearts, but no major changes were observed between PBS and CDC injection groups ( Figure 4D ). Inflammation was also involved in aging. We found inflammation-related genes were increased in aging mouse hearts, including Il-1β, Il-6, and Il-10, but no differences existed between PBS and CDC injection groups ( Figure 4E ). Therefore, we conclude that CDC injection has no effect on cardiac aging-related mRNAs, microRNAs, or inflammation genes. In addition, aging-induced cardiomyocyte hypertrophy was observed in aging mice through wheat germ agglutinin staining, but the cell areas were comparable between PBS and CDC injection groups ( Figure 4F and 4G ).
Telomere length is highly correlated to aging status. Younger hearts have longer telomeres. To verify the rejuvenation ability of CDCs on telomere, we measured the cardiac telomeres at 1 month after injection of PBS and CDCs through fluorescence in situ hybridization with a telomere probe ( Figure 5A ). Our end point staining of telomeres in LV cardiomyocytes showed comparable telomere lengths between PBS-and CDC-injected mice ( Figure 5B through 5E ). To further corroborate the results, we used real-time PCR to quantitate the relative telomere lengths. Compared with the telomere length in young hearts, the telomere length in aging mouse hearts showed ≈35% telomere shortening. After CDC injection, no significant differences were observed between PBS-and CDC-injected hearts ( Figure 5F ).
Evaluation of Exercise Capacity, Hair Regrowth Capacity, and Inflammation
Aging is highly associated with changed systemic performances, including exercise capacity, hair regrowth, inflammation, etc. Our data showed that body weights were similar in both animal groups (30.71±0.43 versus 31.05±0.33 g) after PBS and CDC injection ( Figure 6A ; Online Table III groups (n=5 for each group) . B, Real-time polymerase chain reaction (PCR) showed the expression of fibrotic marker Ctgf in mouse hearts (n=6 for each group). C, Real-time PCR showed the expression of cell cycle and aging-related markers in mouse hearts (n=6 for each group). D, Real-time PCR showed the expression of aging-related microRNAs in mouse hearts (n=6 for each group). E, Real-time PCR showed the expression of inflammation genes in mouse hearts (n=6 for each group). F, Wheat germ agglutinin (WGA) staining showed comparable cardiomyocytes sizes in PBS-and CDC-injected hearts (n=5 for each group). Bar, 20 μm. G, Statistic analysis of cell areas from WGA staining using image J software. *P<0.05, **P<0.01; NS indicates not significant, as indicated, ANOVA. Each experiment was performed 3×. α-SA indicates α-actinin (sarcomeric); IL, interleukin; IS, injection site; and TNF, tumor necrosis factor.
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October 26, 2018 Figure 6B ). We also checked the hair regrowth after depilation in aging mice. Hair regrowth area rates and length were found to have decreased in aging mice (Online Figure II) , but we did not find a significant difference (55.3%±3.7% versus 57.6%±2.3%) on the area rates of hair regrowth after depilation between PBS-and CDC-injected mice ( Figure 6C and 6D ). Moreover, the hair regrowth lengths were comparable between PBS and CDC groups ( Figure 6E ). In addition, the sera from PBS-and CDC-injected mice were collected for systemic inflammation examination. ELISA assays showed the comparable levels of IL-1β, IL-6, and TNF-α between PBS-and CDC-injected groups ( Figure 6F ). Based on our data, CDCs have no overall positive effect on systemic rejuvenation.
Discussion
In the present study, we tested the feasibility of CDC therapy on cardiac dysfunction of aging mice. Unfortunately, we found the cardiac injection of CDCs isolated from neonatal mice could not improve aging heart function and systemic aging performances. In addition, aging-related genes (Serca2, Lpl, and p16), [21] [22] [23] microRNAs (miR-21, miR-22, and miR-34a), [24] [25] [26] and inflammation genes were not affected by CDC transplantation. To confirm the successful transplantation of CDCs, we tracked the injected cells carrying firefly luciferase in vivo with bioluminescence imaging. As shown in Online Figure III , bioluminescence imaging demonstrated that strong firefly luciferase activity was observed at day 1 after cell injection, and the bioluminescence signal was gradually decreased in 4 weeks. CDCs were initially considered as a promising candidate for cell therapy of cardiac injury post-myocardial infarction. Various studies have reported CDCs were beneficial to the cardiac function of injured heart; 27-31 however, the Figure 6 . Exercise, hair regrowth capacities, and inflammation in aging mice. A, Body weights were similar in both PBS-(n=15) and cardiospherederived cell (CDC)-injected (n=19) group. B, The treadmill exercise capacities of aging mice were comparable in both PBS-and CDC-injected groups (n=10 for each group). C, Representative images of hair regrowth 20 d after depilation in aging mice injected with PBS (n=15) and CDCs (n=19). D, Quantitative analysis of regrowth area/depilation area indicated that both PBS-and CDC-injected mice showed comparable hair regrowth capacities (PBS, n=15; CDCs, n=19). E, Both groups showed similar hair regrowth lengths (n=5 for each group In addition, recent studies showed that intramyocardial injection of human CDCs into rat myocardial infarcted heart could not improve heart function and infarct area. 34 Meanwhile, CDCs transplantation resulted in little or mild LVEF improvement in large animal models. [35] [36] [37] Because of the contradictory results, the application of CDCs in clinic should be carefully reevaluated. It is reported that neonatal CDCs are superior to the adult CDCs, and the quality of CDCs decreases with age in terms of proliferation, cardiomyogenic ability, angiogenic function, and other measures. 13, 31, 38, 39 In our study, we found even neonatal CDCs could not benefit the aging heart. Above all, these results indicate CDCs could not effectively regenerate or rejuvenate the heart.
A previous study in rat model indicated that injection of CDCs into the aging animal could systematically benefit the animal based on improvements in heart function, exercise capacity, and hair regrowth. 12 In addition to heart function that was initially tested in our hypothesis, we also tested the exercise capacity, hair regrowth, and inflammation in our study, which unlike the previous study were not found to differ significantly between PBS-and CDC-injected aging mice. The discrepancies between the 2 studies could be because of the differences in animal species, laboratories, and transplantation strategies. In the rat study, CDCs were injected into LV cavity along with simultaneous aortic clamping or directly injected into the myocardium. These 2 methods actually could produce different abilities of cell retention in the heart. Moreover, data from these 2 strategies were subjected not to separated analysis but mixed analysis, which might bring statistical issues. 12 In our study, we performed only intramyocardial injection to enhance retention of CDCs and demonstrated that CDCs did not improve aging heart function. Meanwhile, to get enough cells, our study used passage 5 CDCs, whereas the rat study used passage 2 CDCs. CDCs that were capable of long-term self-renewal could be passaged in cardiosphere-growing medium every 2 to 3 days at 1:2 ratio. 13 Thus, our passage 5 cells were ≈6 to 9 days older than passage 2 cells in vitro. Although passage 5 cells showed typical CDCs characteristics still, their potential for a different rejuvenation capacity and should be further investigated.
LVEF is the volumetric fraction of blood ejected from the LV of the heart into systemic circulation, which is often considered as the value of systolic capacity. In our study, through both echocardiography and pressure-volume loop, we found the LVEF showed comparable values in both PBS-and CDCinjected mice. Although the LVEF was comparatively normal, the reduction of LV volume at end diastole could result in the lower cardiac output, which is thought as the dangerous factor of heart. In our study, we found the LV volume at end diastole was significantly reduced after CDC injection. Similarly, LV internal dimension at end diastole was also significantly reduced after CDC injection. It seems that CDC injection may worsen cardiac function. The LVPW; d measurements are used to determine LV hypertrophy, which is the thickness of the muscle of the LV. LV hypertrophy is a marker for heart disease. We also found the LVPW; d was significantly thicker in CDC group than that in PBS group, indicating CDC injection into the aging hearts might lead to heart hypertrophy. However, we did not observe increased cardiomyocytes areas in CDC-injected hearts through wheat germ agglutinin staining, indicating the cell size was not the reason for LVPW; d thickening. We think that the injection of cells may result in thickening of LVPW; d compared with PBS. Although the mechanism for LVPW; d thickening is unknown, it is clear that CDCs cannot improve aging-induced heart dysfunction.
Many patients have normal LV systolic function but have abnormal diastolic function. Abnormality of diastolic function is highly related to aging. 40 Diastole in the cardiac cycle is a period of relaxation of the heart muscle accompanied by the filling of the chambers with blood. Doppler echocardiography is used to assess diastolic function. The E/A ratio provides a rough impression of diastolic function, and E/Eʹ is viewed as convincing evidence of myocardial diastolic dysfunction. In our study, we did not find any significant differences in term of E/A and E/Eʹ. Collectively, our data indicate that CDCs do not benefit systolic and diastolic functions of aging mouse hearts.
In summary, our study tested whether CDC injection into aging mouse hearts could improve heart function and systemic aging performances (exercise capacity, hair regrowth, and inflammation). Our results indicate that injecting CDCs does not help rescue cardiac function or improve physiological systemic aging performances.
